Stromal retinoic acid receptor β promotes mammary gland tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 2, 2011, Pages 774-779

  Liu, Xingxing ^a   Nugoli, Mélanie ^a   Laferrière, Julie ^a   Saleh, Sadiq M ^a,b,c   Rodrigue Gervais, Ian G ^c   Saleh, Maya ^a,c   Park, Morag ^a,c   Hallett, Michael T ^a,b,c   Muller, William J ^a,c   Giguère, Vincent ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Oncogene; Retinoid; Stromal derived factor 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; RETINOIC ACID RECEPTOR BETA; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATORY CELL; MAMMARY GLAND; MICRODISSECTION; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR GROWTH;

ANIMALS; CHEMOKINE CXCL12; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; ONCOGENES; RECEPTOR, ERBB-2; RECEPTORS, CXCR4; RECEPTORS, RETINOIC ACID; RETINOIDS; SIGNAL TRANSDUCTION; STROMAL CELLS;

MUS;

EID: 79551654966     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011845108     Document Type: Article

References (45)

1. Maden M, Hind M (2003) Retinoic acid, a regeneration-inducing molecule. Dev Dyn 226:237-244.
2. Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134:921-931.
3. Noy N (2010) Between death and survival: Retinoic acid in regulation of apoptosis. Annu Rev Nutr 30:201-217.
4. Mark M, Ghyselinck NB, Chambon P (2006) Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46:451-480.
5. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129:723-733.
6. Hua S, Kittler R, White KP (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137:1259-1271.
7. Ross-Innes CS, et al. (2010) Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev 24:171-182.
8. Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181-193. (Pubitemid 33741893)
9. Rosenauer A, et al. (1998) Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression. Cancer Res 58:5110-5116.
10. Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R (2000) 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60:2040-2048.
11. Moon RC, Constantinou AI (1997) Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Breast Cancer Res Treat 46:181-189.
12. Donato LJ, Noy N (2005) Suppression of mammary carcinoma growth by retinoic acid: Proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res 65:8193-8199.
13. Donato LJ, Suh JH, Noy N (2007) Suppression of mammary carcinoma cell growth by retinoic acid: The cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res 67:609-615.
14. Rao GN, Ney E, Herbert RA (1998) Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Res Treat 48:265-271. (Pubitemid 28159954)
15. Rao GN, Ney E, Herbert RA (1999) Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene. Breast Cancer Res Treat 58:241-254.
16. Alvarez S, et al. (2007) Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor. Int J Biochem Cell Biol 39:1406-1415.
17. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17-23.
18. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46-54.
19. Sappino AP, Skalli O, Jackson B, Schürch W, Gabbiani G (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41:707-712.
20. Li H, Fan X, Houghton J (2007) Tumor microenvironment: The role of the tumor stroma in cancer. J Cell Biochem 101:805-815. (Pubitemid 47040863)
21. Allinen M, et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17-32. (Pubitemid 38903159)
22. Orimo A, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348.
23. Hall JM, Korach KS (2003) Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17:792-803.
24. Cabioglu N, et al. (2005) CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res 65:6493-6497.
25. Finak G, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518-527. (Pubitemid 351655218)
26. Chiesa MD, et al.; Italian Oncology Group for Clinical Research (2007) Tamoxifen vs tamoxifen plus 13-cis-retinoic acid vs tamoxifen plus interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: Updated results of a phase II, prospective, randomised multicentre trial. Acta Biomed 78:204-209.
27. Singletary SE, et al. (2002) Phase II clinical trial of N-(4-hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res 8:2835-2842.
28. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035.
29. Mikkelsen S, Berne B, Staberg B, Vahlquist A (1998) Potentiating effect of dietary vitamin A on photocarcinogenesis in hairless mice. Carcinogenesis 19:663-666. (Pubitemid 28376811)
30. Albright CD, Salganik RI, Van Dyke T (2004) Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth andmetastasis in transgenicmice. J Nutr 134:1139-1144.
31. Møllersen L, Paulsen JE, Olstørn HB, Knutsen HK, Alexander J (2004) Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis 25:149-153.
32. Omenn GS, et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155.
33. Luo J, Pasceri P, Conlon RA, Rossant J, Giguère V (1995) Mice lacking all isoforms of retinoic acid receptor β develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech Dev 53:61-71.
34. Watson CJ, Khaled WT (2008) Mammary development in the embryo and adult: A journey of morphogenesis and commitment. Development 135:995-1003.
35. Andrechek ER, et al. (2000) Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci USA 97:3444-3449.
36. Hodgson JG, et al. (2005) Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 65: 9695-9704.
37. Guy CT, et al. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89:10578-10582.
38. Levental KR, et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891-906.
39. Dillon RL, et al. (2009) Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. Cancer Res 69:5057-5064.
40. Li YM, et al. (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:459-469.
41. Lynch RA, Etchin J, Battle TE, Frank DA (2007) A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells. Cancer Res 67:1254-1261. (Pubitemid 46270785)
42. Widschwendter A, et al. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8:3065-3074.
43. Liu X, et al. (2005) Evolutionary conservation of the clk-1-dependentmechanism of longevity: Loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev 19:2424-2434.
44. Deome KB, Faulkin LJ, Jr., Bern HA, Blair PB (1959) Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19:515-520.
45. Diehn M, et al. (2009) Association of reactive oxygen species levels and radio-resistance in cancer stem cells. Nature 458:780-783.